Strategic partnership Recent and upcoming partnerships with WLH Consulting and Prominence Advisors signal enhanced credibility and expanded go-to-market reach in biopharma analytics; leverage these alliances to co-sell analytics offerings and access broader client networks.

Acquisition backdrop Prominence Advisors acquired Tegra Analytics in 2025, indicating consolidation in life sciences data and analytics services; position as a specialist capability within Prominence’s ecosystem to secure renewal opportunities and cross-sell advanced analytics.

Lifecycle customers Focus on life science sales and marketing teams across pharmaceutical, biologics, biotech, dental, and medical devices sectors presents multiple entry points for visualization, reporting, and consulting services during product launches, launches, and market access efforts.

Tech-enabled value Established tech stack on AWS and web visualization standards enables scalable analytics delivery; pitch for large-scale data-driven decision support with secure cloud-based dashboards and customizable reports.

Revenue potential Current revenue in the mid-range with a small-to-mid-sized team suggests opportunity to scale through expand-to-upsell into Prominence Advisors’ client base and joint offerings, targeting mid-market pharma and medtech accounts seeking precision analytics.